Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: Market Pathways January 2025

Market Pathways' editors highlight the major medtech policy issues and developments they'll be tracking in 2025 and count down the top 10 global policy documents of 2024; Former CMS medical director Lee Fleisher shares his views on the major reimbursement challenges currently facing product companies. In Consultants Corner, MCRA executives offer practical guidance on diversifying device trials and implementing diversity action plans.

Read Article